Protein-bound drugs are prone to sequestration in the ECMO circuit

Kiran Shekar, Jason A Roberts, Charles I Mcdonald, Sussan Ghassabian, Chris Anstey, Steven C Wallis, Daniel V Mullany , Yoke L Fung , John F Fraser

Introduction: Vital drugs may be degraded or sequestered in extracorporeal membrane oxygenation (ECMO) circuits, with lipophilic drugs considered to be particularly vulnerable. However, the circuit effects on protein-bound drugs have not been fully elucidated. The aim of this experimental study was to investigate the influence of plasma protein binding on drug disposition in ex vivo ECMO circuits.

Previous
Previous

Increased sedation requirements in …

Next
Next

Sequestration of drugs in the circuit may lead …